Logo image of CHKP

CHECK POINT SOFTWARE TECH (CHKP) Stock Fundamental Analysis

NASDAQ:CHKP - Nasdaq - IL0010824113 - Common Stock - Currency: USD

230.2  +6.72 (+3.01%)

After market: 230.2 0 (0%)

Fundamental Rating

7

Overall CHKP gets a fundamental rating of 7 out of 10. We evaluated CHKP against 283 industry peers in the Software industry. CHKP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CHKP is not valued too expensively and it also shows a decent growth rate. These ratings could make CHKP a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CHKP had positive earnings in the past year.
In the past year CHKP had a positive cash flow from operations.
Each year in the past 5 years CHKP has been profitable.
CHKP had a positive operating cash flow in each of the past 5 years.
CHKP Yearly Net Income VS EBIT VS OCF VS FCFCHKP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

CHKP has a Return On Assets of 14.72%. This is amongst the best in the industry. CHKP outperforms 90.46% of its industry peers.
CHKP has a Return On Equity of 30.32%. This is amongst the best in the industry. CHKP outperforms 91.52% of its industry peers.
CHKP has a better Return On Invested Capital (19.96%) than 95.41% of its industry peers.
CHKP had an Average Return On Invested Capital over the past 3 years of 20.08%. This is significantly above the industry average of 10.81%.
Industry RankSector Rank
ROA 14.72%
ROE 30.32%
ROIC 19.96%
ROA(3y)14.47%
ROA(5y)14.34%
ROE(3y)29.1%
ROE(5y)27.36%
ROIC(3y)20.08%
ROIC(5y)19.45%
CHKP Yearly ROA, ROE, ROICCHKP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of CHKP (32.97%) is better than 94.35% of its industry peers.
In the last couple of years the Profit Margin of CHKP has declined.
CHKP has a Operating Margin of 34.15%. This is amongst the best in the industry. CHKP outperforms 96.11% of its industry peers.
In the last couple of years the Operating Margin of CHKP has declined.
Looking at the Gross Margin, with a value of 87.55%, CHKP belongs to the top of the industry, outperforming 93.64% of the companies in the same industry.
In the last couple of years the Gross Margin of CHKP has remained more or less at the same level.
Industry RankSector Rank
OM 34.15%
PM (TTM) 32.97%
GM 87.55%
OM growth 3Y-6.58%
OM growth 5Y-5.03%
PM growth 3Y-4.32%
PM growth 5Y-4.45%
GM growth 3Y-0.2%
GM growth 5Y-0.37%
CHKP Yearly Profit, Operating, Gross MarginsCHKP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

CHKP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CHKP has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHKP has less shares outstanding
CHKP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHKP Yearly Shares OutstandingCHKP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CHKP Yearly Total Debt VS Total AssetsCHKP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 9.56 indicates that CHKP is not in any danger for bankruptcy at the moment.
CHKP's Altman-Z score of 9.56 is amongst the best of the industry. CHKP outperforms 84.45% of its industry peers.
CHKP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.56
ROIC/WACC2.19
WACC9.11%
CHKP Yearly LT Debt VS Equity VS FCFCHKP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

CHKP has a Current Ratio of 1.13. This is a normal value and indicates that CHKP is financially healthy and should not expect problems in meeting its short term obligations.
CHKP has a Current ratio of 1.13. This is in the lower half of the industry: CHKP underperforms 69.61% of its industry peers.
A Quick Ratio of 1.13 indicates that CHKP should not have too much problems paying its short term obligations.
CHKP has a Quick ratio of 1.13. This is in the lower half of the industry: CHKP underperforms 68.90% of its industry peers.
CHKP does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
CHKP Yearly Current Assets VS Current LiabilitesCHKP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

CHKP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.53%, which is quite good.
Measured over the past years, CHKP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.26% on average per year.
The Revenue has been growing slightly by 6.22% in the past year.
CHKP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.16% yearly.
EPS 1Y (TTM)8.53%
EPS 3Y9.12%
EPS 5Y8.26%
EPS Q2Q%5.06%
Revenue 1Y (TTM)6.22%
Revenue growth 3Y5.78%
Revenue growth 5Y5.16%
Sales Q2Q%6.06%

3.2 Future

The Earnings Per Share is expected to grow by 11.65% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.59% on average over the next years.
EPS Next Y10.5%
EPS Next 2Y9.86%
EPS Next 3Y10.56%
EPS Next 5Y11.65%
Revenue Next Year6.24%
Revenue Next 2Y5.88%
Revenue Next 3Y5.9%
Revenue Next 5Y5.59%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHKP Yearly Revenue VS EstimatesCHKP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
CHKP Yearly EPS VS EstimatesCHKP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.13, CHKP can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CHKP is valued a bit cheaper than 74.91% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, CHKP is valued at the same level.
With a Price/Forward Earnings ratio of 22.74, CHKP is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHKP indicates a somewhat cheap valuation: CHKP is cheaper than 75.62% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. CHKP is around the same levels.
Industry RankSector Rank
PE 25.13
Fwd PE 22.74
CHKP Price Earnings VS Forward Price EarningsCHKP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

79.15% of the companies in the same industry are more expensive than CHKP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CHKP is valued a bit cheaper than the industry average as 77.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.67
EV/EBITDA 24.05
CHKP Per share dataCHKP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CHKP has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.39
PEG (5Y)3.04
EPS Next 2Y9.86%
EPS Next 3Y10.56%

0

5. Dividend

5.1 Amount

CHKP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHECK POINT SOFTWARE TECH

NASDAQ:CHKP (3/7/2025, 8:13:34 PM)

After market: 230.2 0 (0%)

230.2

+6.72 (+3.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-30 2025-01-30/bmo
Earnings (Next)04-23 2025-04-23/bmo
Inst Owners72.55%
Inst Owner Change1.81%
Ins Owners22.62%
Ins Owner ChangeN/A
Market Cap25.32B
Analysts71.36
Price Target234.28 (1.77%)
Short Float %3.66%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.13%
Min EPS beat(2)-1.99%
Max EPS beat(2)-0.28%
EPS beat(4)0
Avg EPS beat(4)-0.98%
Min EPS beat(4)-1.99%
Max EPS beat(4)-0.23%
EPS beat(8)4
Avg EPS beat(8)0.43%
EPS beat(12)7
Avg EPS beat(12)0.75%
EPS beat(16)11
Avg EPS beat(16)1.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.58%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-1.24%
Revenue beat(4)0
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-1.24%
Revenue beat(8)0
Avg Revenue beat(8)-1.63%
Revenue beat(12)0
Avg Revenue beat(12)-1.34%
Revenue beat(16)1
Avg Revenue beat(16)-1.19%
PT rev (1m)16.1%
PT rev (3m)17.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.81%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)-0.22%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.47%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE 25.13
Fwd PE 22.74
P/S 9.87
P/FCF 23.67
P/OCF 23.14
P/B 9.08
P/tB 28.37
EV/EBITDA 24.05
EPS(TTM)9.16
EY3.98%
EPS(NY)10.12
Fwd EY4.4%
FCF(TTM)9.73
FCFY4.23%
OCF(TTM)9.95
OCFY4.32%
SpS23.32
BVpS25.36
TBVpS8.11
PEG (NY)2.39
PEG (5Y)3.04
Profitability
Industry RankSector Rank
ROA 14.72%
ROE 30.32%
ROCE 23.06%
ROIC 19.96%
ROICexc 31.24%
ROICexgc 143.02%
OM 34.15%
PM (TTM) 32.97%
GM 87.55%
FCFM 41.71%
ROA(3y)14.47%
ROA(5y)14.34%
ROE(3y)29.1%
ROE(5y)27.36%
ROIC(3y)20.08%
ROIC(5y)19.45%
ROICexc(3y)33.3%
ROICexc(5y)32.28%
ROICexgc(3y)126.26%
ROICexgc(5y)98.44%
ROCE(3y)23.2%
ROCE(5y)22.46%
ROICexcg growth 3Y31.08%
ROICexcg growth 5Y27.01%
ROICexc growth 3Y-0.27%
ROICexc growth 5Y2.68%
OM growth 3Y-6.58%
OM growth 5Y-5.03%
PM growth 3Y-4.32%
PM growth 5Y-4.45%
GM growth 3Y-0.2%
GM growth 5Y-0.37%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 28.95%
Cap/Sales 0.94%
Interest Coverage 250
Cash Conversion 114.01%
Profit Quality 126.5%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 9.56
F-Score6
WACC9.11%
ROIC/WACC2.19
Cap/Depr(3y)43.08%
Cap/Depr(5y)50.45%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.87%
Profit Quality(3y)127.63%
Profit Quality(5y)132.68%
High Growth Momentum
Growth
EPS 1Y (TTM)8.53%
EPS 3Y9.12%
EPS 5Y8.26%
EPS Q2Q%5.06%
EPS Next Y10.5%
EPS Next 2Y9.86%
EPS Next 3Y10.56%
EPS Next 5Y11.65%
Revenue 1Y (TTM)6.22%
Revenue growth 3Y5.78%
Revenue growth 5Y5.16%
Sales Q2Q%6.06%
Revenue Next Year6.24%
Revenue Next 2Y5.88%
Revenue Next 3Y5.9%
Revenue Next 5Y5.59%
EBIT growth 1Y-2.57%
EBIT growth 3Y-1.17%
EBIT growth 5Y-0.13%
EBIT Next Year7.42%
EBIT Next 3Y6.88%
EBIT Next 5YN/A
FCF growth 1Y4.95%
FCF growth 3Y-3.43%
FCF growth 5Y-0.16%
OCF growth 1Y5.41%
OCF growth 3Y-3.14%
OCF growth 5Y-0.19%